IGHG3 and B-cell non-Hodgkin lymphoma: In fact, RTX-IgG2 binds CD20+ B-cell lymphoma cells at only half the density of RTX-IgG1 and RTX-IgG3 (Supplementary Figure S7) (37), but induces significantly more apoptosis in these cells (9, 37).